Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PLX

Protalix BioTherapeutics, Inc.

CIK 0001006281 · NYSE American

NYSE AmericanHealth CareBiological Products, (No Diagnostic Substances)
$2.38
↑ 0.00 (0.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$191.76M
P/E Ratio
10.12
EPS
-0.08
Dividend Yield
Not covered
52W Position
51%
Beta
1.30

Valuation multiples

Fwd P/E
11.39
PEG
-0.10
P/B
2.69
P/S
2.38
EV/Revenue
2.04
ROE
26.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 51%
$1.52$3.19

Latest Financials

2025-12-31 FY
Revenue
$52.74M
Net Income
-$6.60M
Total Assets
$82.35M
Free Cash Flow
-$13.63M

Recent news